Full-Time

Director – Strategic Marketing and Business Analytics

Posted on 7/31/2024

Twist Bioscience

Twist Bioscience

1,001-5,000 employees

Produces synthetic DNA for biotechnology applications

Compensation Overview

$202k - $249k/yr

+ Bonus + Equity

Senior, Expert

Oakland, CA, USA

Field-based role in San Francisco Bay Area, CA.

Category
Business Research
Project Management
Strategy Development
Business & Strategy
Growth & Marketing
Required Skills
Market Research
Business Analytics
Data Analysis
Requirements
  • 10+ years of experience in strategic marketing within the life sciences or biotechnology industry, or in business analytics, data analysis or a related field.
  • Strong understanding of the synthetic biology market and its key applications.
  • Experience in B2B, e-commerce, and digital marketing strategies and tactics, is desired.
  • Excellent communication, collaboration, and interpersonal skills, with the ability to translate technical concepts into clear and actionable insights for all levels of the organization.
  • Strong leadership skills with the ability to motivate and inspire a team.
  • Ability to work effectively in a fast-paced, dynamic environment.
  • A passion for science and technology, and a strong desire to make a positive impact on the world.
Responsibilities
  • Lead the development and execution of a comprehensive portfolio and marketing strategy aligned with Twist Bioscience's business objectives and market opportunities.
  • Lead the product and marketing analytics function, fostering a culture of data-driven decision making and collaboration across the organization.
  • Bridge technology/product roadmaps to executive and customer facing communications.
  • Conduct in-depth market research and competitive analysis to identify new market opportunities and inform product marketing strategies.
  • Stay up-to-date on the latest marketing trends and technologies within the life sciences industry.
  • Develop and present market research and marketing reports to senior management, outlining key insights and recommendations for optimizing portfolio strategy and marketing effectiveness.
  • Conduct in-depth data analysis to identify opportunities for revenue growth, cost optimization, and process improvement.
  • Design and develop advanced analytical models and dashboards to track key business metrics, identify trends, and provide insights for optimizing performance.
  • Utilize data visualization tools to communicate complex data insights in a clear and concise manner to both technical and non-technical audiences.
  • Develop and maintain strong relationships with IT, finance, and other departments to ensure smooth data access and integration.
  • Stay up-to-date on the latest trends and technologies in business analytics and artificial intelligence.
  • Lead the development and implementation of a data governance framework to ensure data quality and security. Identify and implement new data-driven tools and technologies to enhance analytical capabilities.
  • Manage the marketing budget and identify opportunities for maximizing ROI.

Twist Bioscience specializes in the synthesis of synthetic DNA, which is essential for various applications in biotechnology, pharmaceuticals, and research. The company produces high-quality DNA sequences that clients, including academic institutions and pharmaceutical companies, use for developing new drugs, diagnosing diseases, and conducting genetic research. Twist Bioscience differentiates itself by offering competitive pricing and a proprietary platform that allows for quick and accurate DNA production. This platform utilizes a smart algorithm to provide instant feedback on the synthesizability of DNA sequences. Their product range includes genes, oligo pools, variant libraries, and tools for SARS-CoV-2, along with DNA data storage and next-generation sequencing services. The company's goal is to be a leading supplier in the synthetic biology market, providing thousands of genes rapidly and effectively, thus supporting a wide array of research projects.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

South San Francisco, California

Founded

2013

Simplify Jobs

Simplify's Take

What believers are saying

  • Collaboration with Absci enhances capabilities in AI-driven antibody discovery.
  • Partnership with MedGenome positions them as a key player in precision medicine.
  • Launch of CHO Express Antibodies expands their market share in antibody production.

What critics are saying

  • Increased competition from companies like Ginkgo Bioworks could impact market share.
  • Dependency on AI technologies may pose risks if not managed properly.
  • New CIO appointment may lead to transitional challenges in IT strategy and operations.

What makes Twist Bioscience unique

  • Twist Bioscience uses a unique silicon-based DNA synthesis platform for precision and scale.
  • They offer high-quality DNA sequences at competitive prices, attracting diverse clients.
  • Their proprietary platform provides instant feedback on DNA sequence synthesis feasibility.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Disability Insurance

Life Insurance

401(k) Retirement Plan

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-1%

2 year growth

-1%
TipRanks
Nov 26th, 2024
Twist Bioscience named a Best Idea for 2025 at TD Cowen

Twist Bioscience named a Best Idea for 2025 at TD Cowen.

SynBioBeta
Oct 31st, 2024
Absci and Twist Bioscience Team Up to Redefine Antibody Discovery with AI

Absci, a pioneer in generative AI-driven drug discovery, and Twist Bioscience, a leader in high-quality synthetic DNA production through its silicon platform, have announced an innovative collaboration to create a novel therapeutic antibody using generative AI.

Investing.com
Oct 25th, 2024
Twist Bioscience president sells $97,428 in stock

In other recent news, Twist Bioscience has secured a $15 million capital boost from a new financial agreement with XOMA Royalty Corporation.

Bakersfield.com
Oct 22nd, 2024
Twist Bioscience Enters into Royalty Purchase Agreement with XOMA Royalty for $15 Million in Cash

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced it has entered into a royalty purchase agreement with XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator.

Stock Titan
Oct 15th, 2024
Twist Bioscience Appoints Mike Fero, Ph.D., as Chief Information Officer

SOUTH SAN FRANCISCO, Calif.-(BUSINESS WIRE)- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the appointment of Mike Fero, Ph.D., as chief information officer.

INACTIVE